IF=15.283,Cancer Communications,華中科技大學(xué)同濟(jì)醫(yī)學(xué)院協(xié)和醫(yī)院,質(zhì)粒.
N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway